New Delhi, May 15 -- India's startup ecosystem is once again turning its attention toward deeptech after the government notified Startup India's Fund of Funds 2.0 with a Rs.10,000 crore corpus. But healthcare is emerging as one of the clearest examples of why deeptech businesses cannot be evaluated through the same lens as software startups.

In healthcare, the real challenge often begins after the product is built. Clinical validation, doctor trust, deployment reliability, regulatory approvals, and workflow integration determine whether a technology survives in real care settings.

Speaking to CiOL, Ashissh Raichura, Founder & CEO, Scanbo Technologies, said India's healthcare deeptech ecosystem still faces a structural gap between policy...